NICU Discharge Criteria for Jaundice in Hyderabad

Overview of Neonatal Jaundice and NICU Discharge

Neonatal jaundice is the most common reason for hospital readmission in the first two weeks of life and a leading cause of NICU admission in India. While the majority of jaundice cases are benign physiological phenomena that resolve spontaneously, pathological hyperbilirubinemia requires prompt identification and treatment to prevent bilirubin encephalopathy and kernicterus, a devastating and preventable neurological condition.

The decision to discharge a neonate who has been treated for jaundice in the NICU involves careful clinical judgment. Discharging too early risks rebound jaundice and readmission, while discharging too late disrupts family bonding and exposes the infant to hospital-acquired infection risks. Evidence-based discharge criteria, structured follow-up protocols, and the availability of post-discharge monitoring and home phototherapy services are essential components of safe jaundice management.

Hyderabad, the capital of Telangana and a major healthcare hub in southern India, has a robust network of government and private NICUs managing neonatal jaundice. This guide examines the discharge criteria, follow-up protocols, and post-discharge care options available in the city.

When to Discontinue Phototherapy

The decision to stop phototherapy precedes discharge and is based on the TSB trajectory relative to age-specific thresholds.

NNF and AAP Recommendations

Phototherapy may be discontinued when TSB has fallen to a level at least 2 to 3 mg per dL below the phototherapy initiation threshold for the infant's current age in hours. For term infants without risk factors, this typically means discontinuing phototherapy when TSB is below 13 to 14 mg per dL after 72 hours of age. For preterm infants and those with risk factors including hemolytic disease, G6PD deficiency, birth asphyxia, and sepsis, more conservative thresholds apply.

The rate of TSB decline during phototherapy is an important indicator. A decline of 0.5 mg per dL per hour or 2 to 3 mg per dL within the first 4 to 6 hours of intensive phototherapy is considered a good response. Failure to achieve this rate should prompt investigation for hemolysis and consideration of treatment escalation.

Assessing Rebound Risk

Not all neonates rebound after phototherapy cessation. Risk factors for clinically significant rebound include the following.

• Gestational age below 37 weeks: preterm infants have immature hepatic conjugation and higher rebound rates
• Hemolytic disease (Rh or ABO incompatibility, G6PD deficiency): ongoing hemolysis drives bilirubin production after phototherapy stops
• Positive direct Coombs test: indicates immune-mediated hemolysis
• Phototherapy initiated before 72 hours of age: suggests early-onset or severe jaundice
• High peak TSB relative to the phototherapy threshold: higher peaks correlate with higher rebound levels

A TSB measurement obtained 12 to 24 hours after discontinuing phototherapy (with the infant in ambient light) is recommended to detect significant rebound before discharge. If TSB rises above the phototherapy threshold during this observation period, phototherapy should be restarted.

NICU Discharge Criteria for Jaundice

The following criteria should be met before a neonate treated for jaundice is discharged from the NICU or special care nursery.

Bilirubin Criteria

1. TSB is declining or stable after phototherapy cessation.
2. Post-phototherapy rebound check shows TSB at least 2 mg per dL below the age-appropriate phototherapy threshold.
3. If hemolytic disease is present, TSB trajectory is stable over at least 24 hours post-phototherapy.
4. Direct bilirubin has been checked and is not disproportionately elevated (direct bilirubin above 20 percent of total warrants investigation for cholestasis).

Feeding and Weight Criteria

1. Infant is feeding well, either breast or formula, with adequate intake demonstrated by at least 8 feeds per day.
2. Weight loss since birth is less than 10 percent for term or less than 15 percent for preterm, with a trajectory towards weight recovery.
3. Urine output is adequate with at least 6 wet nappies per day by day 4 of life.
4. Stool output is transitioning to yellow seedy stools (indicating adequate bilirubin excretion through the gut).

Clinical Criteria

1. Vital signs are stable with normal temperature, heart rate, and respiratory rate.
2. No signs of sepsis, dehydration, or other acute illness.
3. Hearing screening has been completed (bilirubin above 20 mg per dL is a risk factor for auditory neuropathy).
4. Newborn metabolic screening (heel prick for TSH, G6PD, and other conditions) has been collected.

Parental Readiness Criteria

1. Parents are educated about the signs of jaundice and when to seek medical attention.
2. Feeding technique has been assessed and lactation support provided if needed.
3. Follow-up appointment is scheduled within 24 to 48 hours of discharge.
4. Parents have contact information for the NICU or neonatologist for emergency queries.
5. If home phototherapy is planned, the device has been set up and parents trained in its use.

Discharge Readiness Parameter	Standard	Action if Not Met
TSB post-rebound check	≥ 2 mg/dL below phototherapy threshold	Continue observation or restart phototherapy
Feeding adequacy	≥ 8 feeds/day, good latch, adequate output	Lactation support, supplementation if needed
Weight trajectory	< 10% loss, gaining or stable	Feeding optimization, may need IV fluids
Parental education	Demonstrated understanding	Additional teaching, provide written materials
Follow-up arranged	Appointment within 24-48 hours	Arrange before discharge, confirm contact

Post-Discharge Follow-Up Protocols

Structured follow-up after NICU discharge for jaundice is essential for detecting rebound jaundice, ensuring feeding adequacy, and identifying late complications.

Recommended Follow-Up Schedule

• 24 to 48 hours post-discharge: Clinical assessment and bilirubin check (TSB or TcB if appropriate). Assess feeding, weight, hydration, and jaundice progression. This visit is the most critical for detecting early rebound.
• 3 to 5 days post-discharge: Repeat bilirubin if indicated by clinical jaundice. Weight check to confirm gain trajectory. Feeding assessment and lactation support review.
• 2 weeks of age: General well-baby assessment. Bilirubin only if clinically jaundiced. Weight and feeding evaluation. Discuss any pending screening results.
• 4 to 6 weeks of age: Comprehensive follow-up including hearing assessment if TSB was above 20 mg per dL, developmental assessment baseline, and evaluation for prolonged jaundice (visible jaundice beyond 14 days in term or 21 days in preterm warrants investigation for cholestasis and other causes).

Warning Signs for Parents

Parents should be instructed to return to hospital immediately if the baby appears more yellow, especially if yellow colour extends to the legs and soles, the baby becomes lethargic or difficult to wake for feeds, feeding declines significantly, high-pitched cry or arching of the back occurs (potential signs of acute bilirubin encephalopathy), or the baby develops a fever or appears unwell.

Home Phototherapy: A Post-Discharge Option

Home phototherapy has gained acceptance as a safe and clinically effective option for selected neonates with mild residual or late-onset jaundice who do not require hospital-level monitoring.

Eligibility Criteria for Home Phototherapy

• Term or near-term infant (gestational age 35 weeks or above)
• TSB is within 1 to 3 mg per dL of the phototherapy threshold but not in the intensive phototherapy or exchange zone
• No evidence of hemolytic disease or rapid bilirubin rise
• Feeding is well-established with adequate weight gain
• Parents are reliable, educated, and live within reasonable distance of a medical facility
• Follow-up bilirubin testing can be arranged within 24 hours
• A suitable phototherapy device is available for home use

HEAMAC Home Phototherapy in Hyderabad

HEAMAC provides LED phototherapy equipment rental for home use in Hyderabad, enabling families to continue treatment after NICU discharge. The service includes delivery of a calibrated LED phototherapy unit to the home, instruction on device operation, infant positioning, and eye protection, and coordination with the prescribing physician for follow-up bilirubin monitoring. This service reduces hospital occupancy, provides the convenience of home-based treatment, promotes family bonding, and supports breastfeeding continuity. Contact HEAMAC for current rental plans. Home phototherapy through HEAMAC is prescribed and monitored by the treating neonatologist, maintaining clinical oversight throughout the treatment course.

Hyderabad's NICU Landscape for Jaundice Management

Hyderabad has a comprehensive network of hospitals providing neonatal jaundice management from screening through treatment to follow-up care.

Government Hospitals

• Niloufer Hospital: The largest government paediatric hospital in Telangana, Niloufer manages a massive volume of neonatal jaundice cases. Its NICU provides phototherapy and exchange transfusion services. The hospital sees referrals from across Telangana and neighbouring Andhra Pradesh.
• Gandhi Hospital: Government general hospital with a maternity wing and NICU providing phototherapy services.
• Osmania General Hospital: Historic medical institution with neonatal services including jaundice management.

Private Hospitals

• Rainbow Children's Hospital: With multiple locations across Hyderabad including Banjara Hills, LB Nagar, and Marathahalli Road, Rainbow is a premier neonatal care provider. Their jaundice management programme includes universal TcB screening, intensive LED phototherapy, structured discharge protocols, and comprehensive follow-up clinics. Rainbow's neonatologists have published research on jaundice management in Indian neonates.
• Fernandez Hospital: A dedicated maternity and neonatal hospital with locations in Bogulkunta and Hyderguda. Known for evidence-based neonatal care with a strong focus on breastfeeding support, Fernandez has well-defined jaundice discharge protocols and follow-up systems.
• Cloudnine Hospital, Hyderabad: Mother-and-child centre with Level II/III NICU and integrated jaundice management including TcB screening and LED phototherapy.
• KIMS Hospital, Secunderabad: Multi-speciality hospital with a Level III NICU providing comprehensive jaundice management.
• Apollo Hospitals, Jubilee Hills: Tertiary care centre with advanced NICU and neonatal services.
• Continental Hospitals, Gachibowli: Modern hospital with expanding neonatal services in Hyderabad's IT corridor.

Special Considerations for Hyderabad's Healthcare Context

Hyderabad's healthcare delivery for neonatal jaundice operates within several contextual factors. The city's hot climate accelerates dehydration in neonates, which can exacerbate jaundice and complicate feeding. Adequate hydration assessment is a critical component of discharge readiness. The large number of home births and births at small nursing homes means many jaundice cases present late, sometimes with dangerously elevated bilirubin levels. Public awareness campaigns about jaundice recognition are conducted by NNF Telangana chapter and hospital outreach programmes.

The city's geographic spread from Secunderabad in the north to Shamshabad in the south means follow-up logistics can be challenging for families. Decentralized follow-up through neighbourhood clinics and telemedicine consultations is increasingly used by private hospitals to improve follow-up compliance. Telangana's Aarogyasri health insurance scheme covers neonatal jaundice treatment including phototherapy, making hospital-based care financially accessible for eligible families.

Reducing Readmission Rates: Studies from Indian NICUs show that structured discharge protocols and early follow-up can reduce jaundice-related readmission rates by 30 to 50 percent. The combination of evidence-based discharge criteria, parental education, timely follow-up, and home phototherapy availability through services like HEAMAC creates a comprehensive safety net for neonates transitioning from hospital to home care in Hyderabad.

Conclusion

Safe discharge of neonates treated for jaundice requires meeting clear bilirubin, feeding, clinical, and parental readiness criteria. Structured post-discharge follow-up with early bilirubin monitoring is essential for detecting rebound jaundice and ensuring successful transition to home care. Hyderabad's healthcare infrastructure, with its mix of high-volume government hospitals and quality-focused private institutions, provides a strong foundation for neonatal jaundice management. The growing availability of home phototherapy and integrated follow-up systems further enhances the safety and efficiency of the discharge process, ultimately improving outcomes for jaundiced neonates across the city.